HS-1371, a novel kinase inhibitor of RIP3-mediated necroptosis
2018 · Experimental & Molecular Medicine · 103 citations
https://doi.org/10.1038/s12276-018-0152-8
S
Seyeon Park
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
205
Papers
4.6K
Citations
36
h-index
88
i10-index
Seyeon Park is an academic researcher from Dongduk Women's University. The author has contributed to research in topics: Vitamin C and Antioxidants Research & Cancer Immunotherapy and Biomarkers & Phytochemicals and Antioxidant Activities. The author has an h-index of 36, co-authored 175 publications.
ORCID: 0000-0002-2471-3174Papers by this author
worksHigh dose concentration administration of ascorbic acid inhibits tumor growth in BALB/C mice implanted with sarcoma 180 cancer cells via the restriction of angiogenesis
2009 · Journal of Translational Medicine · 80 citations
https://doi.org/10.1186/1479-5876-7-70
Distinct exhaustion features of T lymphocytes shape the tumor-immune microenvironment with therapeutic implication in patients with non-small-cell lung cancer
2021 · Journal for ImmunoTherapy of Cancer · 53 citations
https://doi.org/10.1136/jitc-2021-002780
Enhanced Anticancer Effect of Adding Magnesium to Vitamin C Therapy: Inhibition of Hormetic Response by SVCT-2 Activation
2019 · Translational Oncology · 31 citations
https://doi.org/10.1016/j.tranon.2019.10.017
Reduction in MLKL-mediated endosomal trafficking enhances the TRAIL-DR4/5 signal to increase cancer cell death
2020 · Cell Death and Disease · 29 citations
https://doi.org/10.1038/s41419-020-02941-9
Single-cell analysis reveals cellular and molecular factors counteracting HPV-positive oropharyngeal cancer immunotherapy outcomes
2024 · Journal for ImmunoTherapy of Cancer · 21 citations
https://doi.org/10.1136/jitc-2023-008667
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat